SurvivorNet on MSN
Enabling hope: Lilly’s head of oncology has a hugely ambitious plan to create the next wave of cancer drugs & incredible resources to make it happen
For Jacob Van Naarden, Executive Vice President and President of Lilly Oncology, the mission is clear: bring better cancer ...
After a stunning 703% run-up in price over the past five years, shares of Eli Lilly and Co. have been on a roller-coaster ride since September. The stock, which reached an all-time high of $972 on Aug ...
Eli Lilly's GLP-1 market dominance, supported by superior efficacy and strong manufacturing investments, positions it as a leader alongside Novo Nordisk, with forecasted revenue growth to $75B by 2027 ...
INDIANAPOLIS, Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed ...
Data from Structure Therapeutics and WAVE Life Sciences show that threats to the incumbents’ dominance are on the way.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min This week’s news from the life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback